.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Mallinckrodt
Accenture
Julphar
Chubb
Fuji
Medtronic
Cerilliant
Express Scripts
Covington

Generated: November 21, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,164,377

« Back to Dashboard

Summary for Patent: 5,164,377

Title: Sulphated glycosaminoglycuronan with antithrombotic activity
Abstract:The present invention relates to sulphated glycosamino glycuronan with antithrombotic activity consisting essentially of salts of dermatan sulphate, chondroitin sulphate and heparan sulphate, characterized by a) an average molecular weight between 4000 and 8000 daltons; b) a nitrogen content between 2.4 and 3.0%; c) a sulphur content between 7.5 and 9.5%; d) a sodium content between 9 and 11%; e) a dermatan sulphate content between 5 and 25%; f) a chondroitin sulphate content less than 9%; g) an anti-Xa activity between 11 and 20 .mu./mg; and h) an antithrombin III dependent antithrombin activity of less than 1 .mu./mg.
Inventor(s): Van Dedem; Gijsbert W. K. (Oss, NL), Van Hou Denhoven; Francois E. A. (Heesch, NL), Meuleman; Dirk G. (Oss, NL), Moelker; Huibert C. T. (Megen, NL), Sanders; Adrianus L. M. (Uden, NL)
Assignee: Akzo N.V. (Arnhem, NL)
Application Number:07/592,152
Patent Claim Types:
see list of patent claims
Compound; Formulation; Device; Composition;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,164,377

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
89202494.4Oct 04, 1989

International Patent Family for Patent: 5,164,377

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada2026036► Subscribe
Germany69005251► Subscribe
Denmark0421508► Subscribe
European Patent Office0421508► Subscribe
Spain2062307► Subscribe
Australia637143► Subscribe
Australia6323890► Subscribe
Austria98656► Subscribe
Finland101152► Subscribe
Ireland903366► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Harvard Business School
US Army
McKesson
Dow
QuintilesIMS
Federal Trade Commission
Teva
Medtronic
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot